United Therapeutics signs exclusive pact with Ascendis Pharma

By Admin
United Therapeutics Corporation has signed an exclusive deal with Ascendis Pharma to apply Ascendis Pharmas proprietary TransCon technology platform to...

United Therapeutics Corporation has signed an exclusive deal with Ascendis Pharma to apply Ascendis Pharma’s proprietary TransCon technology platform to United Therapeutics’ treprostinil molecule, the active ingredient in Remodulin® injection.

The company believes that the TransCon technology platform may enable a controlled, long-acting release of a novel, carrier-linked product. This significantly enhances the delivery profile of treprostinil  by establishing a self-injectable alternative for patients who presently use the drug through a continuous infusion pump to treat pulmonary arterial hypertension.

Martine Rothblatt, Ph.D., United Therapeutics’ Chairman and CEO said, “We are thrilled to enter into this license agreement with Ascendis Pharma.” Mr. Rothblatt also said, “The potential to bring another novel therapeutic option to PAH patients represents an exciting new opportunity for Remodulin delivery as we constantly re-charge our mission to better the lives of patients suffering from PAH.” 

Under the terms of the agreement, United Therapeutics will also have exclusive rights to develop prostacyclin, prostacyclin analog and prostacyclin related products to treat PAH using the TransCon technology and will hold worldwide commercial rights to products resulting from the collaboration.

United Therapeutics is a biotechnology company focusing on development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening conditions. 

Share
Share

Featured Articles

UPS Healthcare Addressing Connected Logistics Needs

UPS Healthcare is meeting increased need for integrated, globally connected healthcare logistics services in Republic of Ireland, where pharma is booming

HPV Vaccine 'Protects Males from Cancers' - Global Report

As a new report shows the human papillomavirus vaccine can also protect men and boys, we take a look at HPV vaccines, and their impact on world health

Tata Consultancy Report Shows AI in Healthcare on Rise

Tata Consultancy Services AI for Business Global Study shows that three-quarters of healthcare leaders are deploying AI to drive innovation and efficiency

McKinsey: Consumers Demand Data-driven Wellness Products

Medical Devices & Pharma

SpaceX Starlink Launch Boost for Indonesia Healthcare

Technology & AI

J&J Targets Supplier Sustainability to Cut Healthcare GHGs

Sustainability